---
title: "Guardian Pharmacy Services, Inc. (GRDN.US)"
type: "quote"
locale: "en"
url: "https://longbridge.com/en/quote/GRDN.US.md"
symbol: "GRDN.US"
name: "Guardian Pharmacy Services, Inc."
industry: "Health Care Services"
---

# Guardian Pharmacy Services, Inc. (GRDN.US)

| Item | Detail |
|------|--------|
| Industry | Health Care Services |
| Location | US Market |
| Website | [guardianpharmacy.com](https://guardianpharmacy.com) |

## Company Profile

Guardian Pharmacy Services, Inc., a pharmacy service company, provides a suite of technology-enabled services to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs ...

## Financial Score

> *Longbridge Financial Score™ — Proprietary multi-factor rating model by [Longbridge](https://longbridge.com). This score is independently calculated by Longbridge and is not affiliated with any third-party rating agency.*
> Updated: 2026-03-01T04:30:14.000Z

**Overall: B (0.25)**

**Industry**: Health Care Services

| Metric | Value |
|--------|-------|
| Industry Ranking | 15 / 86 |
| Industry Median | C |
| Industry Average | C |

- **Style**: Blend - Stocks in which the company has both growth and mature businesses.
- **Scale**: Mid - The company has stable operation of a large-cap stock and the high return of a small-cap stock.

### Score Analysis

**Style Score**: 

#### Growth Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | 18.68% |  |
| Net Profit YoY | 117.61% |  |

#### Value Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| P/B Ratio | 11.55 |  |
| Dividend Ratio | 0.00% |  |


**Size Score**: 

#### Market Cap Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 2.12B |  |

#### Revenue Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue | 1.39B |  |


**Multi Score**: B

#### Profit Score: B

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | 11.23% | B |
| Profit Margin | 2.90% | C |
| Gross Margin | 19.80% | D |

#### Growth Score: A

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | 18.68% | B |
| Net Profit YoY | 117.61% | A |
| Total Assets YoY | 12.07% | B |
| Net Assets YoY | 46.01% | A |

#### Cash Score: A

| Indicator | Value | Rating |
|-----------|-------|--------|
| Cash Flow Margin | 7950.33% | A |
| OCF YoY | 18.68% | B |

#### Operating Score: A

| Indicator | Value | Rating |
|-----------|-------|--------|
| Turnover | 3.77 | A |

#### Debt Score: C

| Indicator | Value | Rating |
|-----------|-------|--------|
| Gearing Ratio | 49.88% | C |


```chart-data:radar
{
  "title": "Longbridge Financial Score - Guardian Pharmacy Services, Inc.",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Profit",
      "grade": "B",
      "indicators": [
        {
          "name": "ROE",
          "value": "11.23%",
          "rating": "B"
        },
        {
          "name": "Profit Margin",
          "value": "2.90%",
          "rating": "C"
        },
        {
          "name": "Gross Margin",
          "value": "19.80%",
          "rating": "D"
        }
      ]
    },
    {
      "name": "Growth",
      "grade": "A",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "18.68%",
          "rating": "B"
        },
        {
          "name": "Net Profit YoY",
          "value": "117.61%",
          "rating": "A"
        },
        {
          "name": "Total Assets YoY",
          "value": "12.07%",
          "rating": "B"
        },
        {
          "name": "Net Assets YoY",
          "value": "46.01%",
          "rating": "A"
        }
      ]
    },
    {
      "name": "Cash",
      "grade": "A",
      "indicators": [
        {
          "name": "Cash Flow Margin",
          "value": "7950.33%",
          "rating": "A"
        },
        {
          "name": "OCF YoY",
          "value": "18.68%",
          "rating": "B"
        }
      ]
    },
    {
      "name": "Operating",
      "grade": "A",
      "indicators": [
        {
          "name": "Turnover",
          "value": "3.77",
          "rating": "A"
        }
      ]
    },
    {
      "name": "Security",
      "grade": "C",
      "indicators": [
        {
          "name": "Gearing Ratio",
          "value": "49.88%",
          "rating": "C"
        }
      ]
    }
  ]
}
```

### Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
|------|------|--------|--------|-----------|----------|------|--------|
| 01 | TalkSpace (US.TALK) | C | B | A | A | A | A |
| 02 | Cigna (US.CI) | B | B | A | D | B | B |
| 03 | BrightSpring Health Services - Unit (US.BTSGU) | C | B | A | D | A | B |
| 04 | Labcorp (US.LH) | B | C | B | C | B | B |
| 05 | Quest Diagnostics (US.DGX) | B | B | B | C | B | B |

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | 121.40 | 26/79 | 117.48 | 110.53 | 103.68 |
| PB | 11.55 | 54/79 | 10.73 | 9.93 | 8.84 |
| PS (TTM) | 1.53 | 45/79 | 1.38 | 1.24 | 1.06 |
| Dividend Yield | 0.00% | - | - | - | - |

## Institutional View

### Analyst Rating Distribution

> As of 2026-01-22T05:00:00.000Z

Total Analysts: **4**

| Rating | Count | Percentage |
|--------|-------|-----------|
| Buy | 3 | 75% |
| Overweight | 1 | 25% |
| Hold | 0 | 0% |
| Underweight | 0 | 0% |
| Sell | 0 | 0% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 33.51 |
| Highest Target | 36.00 |
| Lowest Target | 34.00 |

## References

- [Company Overview](https://longbridge.com/en/quote/GRDN.US/overview.md) - Shareholders, executives, business segments
- [Financials](https://longbridge.com/en/quote/GRDN.US/norm.md) - Income statement, balance sheet, cash flow, distribution plan
- [Topics & Discussions](https://longbridge.com/en/quote/GRDN.US/topics.md) - Community topics and discussions

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.